Last reviewed · How we verify
a simulated agent of Jitongning tablets
Jitongning tablets are a simulated agent that works by inhibiting the renin-angiotensin-aldosterone system (RAAS) to lower blood pressure.
Jitongning tablets are a simulated agent that works by inhibiting the renin-angiotensin-aldosterone system (RAAS) to lower blood pressure. Used for Hypertension.
At a glance
| Generic name | a simulated agent of Jitongning tablets |
|---|---|
| Sponsor | Tasly Pharmaceutical Group Co., Ltd |
| Drug class | ACE inhibitor |
| Target | ACE |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | Phase 3 |
Mechanism of action
The exact mechanism of action is not well understood, but it is believed to involve the inhibition of angiotensin-converting enzyme (ACE) and the subsequent reduction of angiotensin II levels. This leads to vasodilation and a decrease in blood pressure.
Approved indications
- Hypertension
Common side effects
- Cough
- Dizziness
- Headache
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: